ichor.bio | 生物相似藥(Biosimilars)系列產品全面八折

ichor.bio | 生物相似藥(Biosimilars)系列產品全面八折

2022.03.01

隨著時間的推進,許多具有專利的大分子蛋白藥物紛紛到期,因此有越來越多廠商投入開發生物相似藥。生物相似藥除了可以提供更多的治療選擇外,透過競爭也可以降低醫療的成本,近年也成為生技產業發展的一個趨勢。

在研究的領域中,亞旭所代理的Ichorbio能以最快的速度提供生物相似藥,並在2022年開始提供超過一百多種的cGMP等級的研究生物相似藥,能成為您實驗最堅強的後盾

 

優惠產品列表:

Cat Number

Name

Target

ICH4001

Adalimumab Biosimilar

TNF Alpha

ICH4002

Alemtuzumab Biosimilar 

CD52

ICH4003

Bevacizumab Biosimilar 

VEGF

ICH4004

Cetuximab Biosimilar

EGFR

ICH4005

Eculizumab Biosimilar 

C5

ICH4006

Infliximab Biosimilar

TNF Alpha

ICH4008

Nimotuzumab Biosimilar

EGFR

ICH4009

Nivolumab Biosimilar

PD-1

ICH4010

Omalizumab Biosimilar

IGE

ICH4011

Rituximab Biosimilar

CD20

ICH4012

Tocilizumab Biosimilar

IL6R

ICH4013

Trastuzumab Biosimilar

ERBB2

ICH4014

Ado-trastuzumab emtansine Biosimilar

ERBB2

ICH4015

Aflibercept Biosimilar

VEGF

ICH4016

Alirocumab Biosimilar

PCSK9

ICH4017

Avelumab Biosimilar

PD-L1

ICH4018

Atezolizumab Biosimilar

PD-L1

ICH4019

Denosumab Biosimilar

RANKL

ICH4020

Daratumumab Biosimilar

CD38

ICH4022

Etanercept Biosimilar

TNF

ICH4023

Evolocumab Biosimilar

PCSK9

ICH4025

Ipilimumab Biosimilar

CTLA-4

ICH4026

Obinutuzumab Biosimilar

CD20

ICH4027

Ofatumumab Biosimilar

CD20

ICH4028

Panitumumab Biosimilar

EGFR

ICH4029

Pembrolizumab Biosimilar

PD-1

ICH4030

Pertuzumab Biosimilar

ERBB2

ICH4031

Ranibizumab Biosimilar

VEGF-A

ICH4032

Ramucirumab Biosimilar

VEGFR2

Cat Number

Name

Target

ICH4033

Secukinumab Biosimilar

IL17A

ICH4034

Ustekinumab Biosimilar

IL12/IL23

ICH4035

Vedolizumab Biosimilar

ITGA4B7

ICH4036

Mepolizumab Biosimilar

IL-5

ICH4037

Natalizumab Biosimilar

IL-5

ICH5001

Sintilimab Biosimilar

PD-1

ICH5002

Toripalimab Biosimilar

PD-1

ICH5003

Camrelizumab Biosimilar

PD-1

ICH5004

Tislelizumab Biosimilar

PD-1

ICH5005

Durvalumab Biosimilar

PD-L1

ICH5006

M7824 Biosimilar

PD-L1 & TGF-B

ICH5007

Naptumomab Biosimilar

5T4

ICH5008

Aducanumab Biosimilar

Amyloid Beta

ICH5009

Gantenerumab Biosimilar

Amyloid Beta

ICH5010

Nesvacumab Biosimilar

ANG2

ICH5011

Belantamab mafodotin Biosimilar

BCMA

ICH5012

Sutimlimab Biosimilar

C1S

ICH5013

Girentuximab Biosimilar

CAIX

ICH5014

Utomilumab Biosimilar

4-1BB

ICH5015

Urelumab Biosimilar

4-1BB

ICH5016

Atibuclimab Biosimilar

CD14

ICH5017

Monalizumab Biosimilar

NKG2A

ICH5018

MDX-1342 Biosimilar

CD19

ICH5019

Glofitamab Biosimilar

CD3/CD20

ICH5020

Moxetumomab pasudotox Biosimilar

CD22

ICH5021

Daclizumab Biosimilar

CD25

ICH5022

Varlilumab Biosimilar

CD27

ICH5023

Theralizumab Biosimilar

CD28

ICH5024

Muromonab-CD3 Biosimilar

CD3E

Cat Number

Name

Target

ICH5025

Blinatumomab Biosimilar

CD3/CD19

ICH5026

Mosunetuzumab Biosimilar

CD3/CD20

ICH5027

Odronextamab Biosimilar

CD3/CD20

ICH5028

Isatuximab Biosimilar

CD38

ICH5029

Ibalizumab Biosimilar

CD4

ICH5030

Dacetuzumab Biosimilar

CD40

ICH5031

Sotigalimab Biosimilar

CD40

ICH5032

Selicrelumab Biosimilar

CD40

ICH5033

SRF231 Biosimilar

CD47

ICH5034

Lemzoparlimab Biosimilar

CD47

ICH5035

CC-90002 Biosimilar

CD47

ICH5036

Magrolimab Biosimilar

CD47

ICH5037

Cusatuzumab Biosimilar

CD70

ICH5038

Oleclumab Biosimilar 

CD73

ICH5039

Polatuzumab vedotin Biosimilar

CD79B

ICH5040

Tusamitamab Biosimilar

CEACAM5

ICH5041

Cibisatamab Biosimilar

CEA/CD3

ICH5042

Tinurilimab Biosimilar

CEACAM6

ICH5043

Erenumab Biosimilar

CGRP receptor

ICH5044

Eptinezumab Biosimilar

CALCA/CALCB

ICH5045

Fremanezumab Biosimilar

CGRP

ICH5046

Galcanezumab Biosimilar

CGRP

ICH5047

Zolbetuximab Biosimilar

Claudin 18.2

ICH5048

Rovalpituzumab Biosimilar

DLL3

ICH5049

Batoclimab Biosimilar

FCRN

ICH5050

Nipocalimab Biosimilar

FCRN

ICH5051

Rozanolixizumab Biosimilar

FCRN

ICH5052

Aprutumab Biosimilar

FGFR

ICH5053

Bemarituzumab Biosimilar

FGFR2B

Cat Number

Name

Target

ICH5054

Mavrilimumab Biosimilar

GMCSF

ICH5055

Codrituzumab Biosimilar

GPC3

ICH5056

Abciximab Biosimilar

GPIIB/GPIIIA

ICH5058

Lebrikizumab Biosimilar

IL-13

ICH5059

Tralokinumab Biosimilar

IL-13

ICH5061

Etokimab Biosimilar

IL-33

ICH5063

Clazakizumab Biosimilar

IL-6

ICH5064

Guselkumab Biosimilar

IL-23

ICH5065

BMS986016 Biosimilar

LAG3

ICH5067

TSR-033 Biosimilar

LAG3

ICH5068

Simtuzumab Biosimilar

LOXL2

ICH5069

Amatuximab Biosimilar

MSLN

ICH5070

Enfortumab vedotin Biosimilar

NECTIN-4

ICH5071

Palivizumab Biosimilar

RSV-F

ICH5072

5G12 Biosimilar

SIGLEC15

ICH5074

KWAR23 Biosimilar

SIRP ALPHA

ICH5075

Elotuzumab Biosimilar

SLAMF7

ICH5076

Sacituzumab Biosimilar

TACSTD2

ICH5077

Fresolimumab Biosimilar

TGFBETA1

ICH5078

Tiragolumab Biosimilar

TIGIT

ICH5079

Sabatolimab Biosimilar

TIM3

ICH5080

Belimumab Biosimilar

TNFSF13B

ICH5081

Onvatilimab Biosimilar

VISTA

ICH5082

Caplacizumab Biosimilar

VWF

back-Top
open-line

LINE 線上諮詢

亞旭-LINE-QRcode

掃瞄或手機直接點擊條碼

error: Content is protected !!